Peptide-specific CTL induction in BHV-seropositive PBMC by stimulation with peptides in vitro: Novel epitopes identified from chronic carriers

Virus Research

Volumn 50, Issue 2, 1997, Pages 185-194

  Lee, Hee Gu ^a   Lim, Jong Seok ^a   Lee, Ki Young ^a   Choi, Yong Kyung ^a   Choe, In Seong ^a   Chung, Tai Wha ^a   Kim, Kilhyoun ^b  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Ewha Womans University   (South Korea)

Author keywords

CTL; Epitope peptide; Hepatitis B virus; HLA A2

Indexed keywords

EPITOPE; HLA A2 ANTIGEN; SYNTHETIC PEPTIDE; VIRUS PROTEIN;

ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; MONONUCLEAR CELL; PRIORITY JOURNAL; VIRUS CARRIER;

CARRIER STATE; CELL LINE; CHRONIC DISEASE; CYTOTOXICITY TESTS, IMMUNOLOGIC; EPITOPES; HEPATITIS B; HEPATITIS B VIRUS; HLA-A2 ANTIGEN; HUMANS; HYBRIDOMAS; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; PEPTIDES; PHENOTYPE; PROTEIN BINDING; T-LYMPHOCYTES, CYTOTOXIC;

HEPATITIS B VIRUS;

EID: 0343118161     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(97)00068-3     Document Type: Article

References (23)

1. Bertoletti, A., Chisari, F.V., Penna, A., Guilhot, S., Galati, L., Fowler, P., Vitiello, A., Chesnut, R.C., Fiaccadori, F., Ferrari, C., 1993. Definition of a minimal optimal cytotoxic T cell epitope within the hepatitis B virus nucleocapsid protein. J. Virol. 67, 2376-2380.
2. Bertoletti, A., Costanzo, A., Chisari, F.V., Levrero, M., Artini, M., Sette, A., Penna, A., Giuberti, T., Fiaccadori, F., Ferrari, C., 1994. Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope. J. Exp. Med. 80, 993-993.
3. Celis, E., Ou, D., Otvos, L. Jr., 1988. Recognition of hepatitis B surface antigen by human T lymphocytes. Proliferative and cytotoxic responses to a major antigenic determinant defined by synthetic peptides. J. Immunol. 140, 1808-1815.
4. Cerny, A., Fowler, P., Brothers, M.A., Houghton, M., Schlicht, H.J., Chisary, F.V., 1995. Induction in vitro of a primary human antiviral cytotoxic T cell response. Eur. J. Immunol. 25, 627-630.
5. Cerundolo, V., Alexander, J., Anderson, K., Lamb, C., Creswell, P., McMichael, A., Gotch, F., Townsend, A., 1990. Presentation of viral antigen controlled by a gene in the major histocompatibility complex. Nature 345, 449-452.
6. Christinck, E.R., Luscher, M.A., Barber, B.H., Williams, D.B., 1991. Peptide binding to class I MHC on living cells and quantitation of complexes required for CTL lysis. Nature 352, 67-70.
7. Falk, K., Rötzschke, O., Stevanovic, S., Jung, G., Rammensee, H.-G., 1993. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351, 290-296.
8. Ferrari, C., Bertoletti, A., Penna, A., Cavalli, A., Missale, G., Pilli, M., Fowler, P., Giuberti, T., Chisari, F.V., Fiaccadori, F., 1991. Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen. J. Clin. Invest. 88, 214-222.
9. Hunt, D.F., Henderson, R.A., Shabanowitz, J., Sakaguchi, K., Michel, H., Sevilir, N., Cox, A.L., Appella, E., Engelhard, V.H., 1992. Characterization of peptide bound to the class I MHC molecule HLA-A2 by mass spectrometry. Science 255, 1261-1263.
10. Kast, W.M., Brandt, R.M.P., Drijfhout, J.W., Melief, C.J.M., 1993. Human leukocyte antigen-A2.1 restricted candidate cytotoxic T lymphocyte epitopes of human papillomavirus type 16 E6 and E7 proteins identified by using the processing-defective human cell line T2. J. Immunother. 14, 115-120.
11. Lim, J.-S., Kim, S., Lee, H.-G., Lee, K.-Y., Kwon, T.-J., Kim, K., 1996. Selection of peptides that bind to the HLA-A2 molecule by molecular modeling. Mol. Immunol. 33, 221-230.
12. Madden, D.R., Garboczi, D.N., Wiley, D.C., 1993. The antigenic identity of peptide-MHC complexes: a comparison of the conformations of five viral peptides presented by HLA-A2. Cell 75, 693-708.
13. Nayersina, R., Fowler, P., Guilhot, S., Missale, G., Cherny, A., Schlicht, H.-J., Vitiello, A., Chesnut, R., Person, J.L., Redeker, A., Chisari, F.V., 1993. HLA-A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. J. Immunol. 150, 4659-4671.
14. Penna, A., Chisari, F.V., Bertoletti, A., Missale, G., Fowler, P., Giuberti, T., Fiaccadori, F., Ferrari, C., 1991. Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen. J. Exp. Med. 174, 1565-1570.
15. Radesevic, K., Garritson, H.S.P., Van Fraft, M., De Grooth, B.G., Grece, J., 1990. A simple and sensitive flow cytometric assay for the determination of the cytotoxic activity of human natural killer cells. J. Immunol. Methods 135, 81-89.
16. Rehermann, B., Pasquinelli, C., Mosier, S.M., Chisari, F.V., 1995. Hepatitis B virus (HBV) sequence variation in cytotoxic T lymphocyte epitopes is not common in patients with chronic HBV infection. J. Clin. Invest. 96, 1527-1534.
17. Rötzschke, O., Falk, K., Deres, K., Schild, H., Norda, M., Metzger, J., Rammensee, H.-G., 1990. Isolation and analysis of naturally processed peptides as recognized by cytotoxic T cells. Nature 348, 252-254.
18. Ruppert, J., Sidney, J., Celis, E., Kubo, R.T., Grey, H.M., Sett, A., 1993. Prominent role of secondary anchor residues in peptide binding to HLA-A2 molecules. Cell 74, 929-937.
19. Sette, A., Vitiello, A., Rehermann, B., Fowler, P., Nayersina, R., Kast, W.M., Melief, C.J.M., Oseroff, C., Yuan, L., Ruppert, J., Sidney, J., del Guercio, M.-F., Southwood, S., Kubo, R.T., Chesnut, R.W., Grey, H.M., Chisari, F.V., 1994. The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J. Immunol. 153, 5587-5592.
20. Stuber, G., Leder, G.H., Storkus, W.J., Lotze, M.T., Modrow, S., Székely, L., Wolf, H., Klein, E., Kärre, K., Klein, G., 1994. Identification of wild-type and mutant p53 peptides binding to HLA-A2 assessed by a peptide loading-deficient cell line assay and a novel major histocompatibility complex class I peptide binding assay. Eur. J. Immunol. 24, 765-768.
21. b molecule. Nature 348, 213-216.
22. Wentworth, P.A., Celis, E., Crimi, C., Stiteli, S., Hale, L., Tsai, V., Serra, H.M., del Guercio, M.-F., Livingston, B., Alazard, D., Fikes, J., Kubo, R.T., Grey, H.M., Chesnut, R.W., Chisari, F.V., Sette, A., 1995. In vitro induction of primary, antigen-specific CTL from human peripheral blood mononuclear cells stimulated with synthetic peptides. Mol. Immunol. 32, 603-610.
23. Wentworth, P.A., Vitiello, A., Sidney, J., Keogh, E., Chesnut, R.W., Grey, H.M., Sette, A., 1996. Differences and similarities in the A2.1-restricted cytotoxic T cell repertoire in humans and human leukocyte antigen-transgenic mice. Eur. J. Immunol. 26, 97-101.